Conversely, CXXC5 is highly expressed in metastatic melanoma, thyroid carcinoma (THCA), BC, endometrial cancer (EC), PCa, and ovarian cancer (OC), suggesting a potential tumor-promoting function (shown in Fig. 4) [48, 87, 91, 92]. Here, CXXC5 is linked to thyroid gland carcinoma.